Literature DB >> 12504288

Preoperative assessment of motor cortex and pyramidal tracts in central cavernoma employing functional and diffusion-weighted magnetic resonance imaging.

Walter Möller-Hartmann1, Timo Krings, Volker A Coenen, Lothar Mayfrank, Jürgen Weidemann, Heidi Kränzlein, Armin Thron.   

Abstract

BACKGROUND: Functional MRI (fMRI) combines anatomic with functional information and has therefore been widely used for preoperative planning of patients with mass lesions affecting functionally important brain regions. However, the courses of functionally important fiber tracts are not visualized. We therefore propose to combine fMRI with diffusion-weighted MRI (DWI) that allows visualization of large fiber tracts and to implement this data in a neuronavigation system.
METHODS: DWI was successfully performed at a field strength of 1.5 Tesla, employing a spin-echo sequence with gradient sensitivity in six noncollinear directions to visualize the course of the pyramidal tracts, and was combined with echo-planar T2* fMRI during a hand motor task in a patient with central cavernoma.
RESULTS: Fusion of both data sets allowed visualization of the displacement of both the primary sensorimotor area (M1) and its large descending fiber tracts. Intraoperatively, these data were used to aid in neuronavigation. Confirmation was obtained by intraoperative electrical stimulation. Postoperative MRI revealed an undisrupted pyramidal tract in the neurologically intact patient.
CONCLUSION: The combination of fMRI with DWI allows for assessment of functionally important cortical areas and additional visualization of large fiber tracts. Information about the orientation of fiber tracts in normal appearing white matter in patients with tumors within the cortical motor system cannot be obtained by other functional or conventional imaging methods and is vital for reducing operative morbidity as the information about functional cortex. This technique might, therefore, have the prospect of guiding neurosurgical interventions, especially when linked to a neuronavigation system.

Entities:  

Mesh:

Year:  2002        PMID: 12504288     DOI: 10.1016/s0090-3019(02)00869-8

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  6 in total

1.  Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery.

Authors:  Neculai Archip; Olivier Clatz; Stephen Whalen; Dan Kacher; Andriy Fedorov; Andriy Kot; Nikos Chrisochoides; Ferenc Jolesz; Alexandra Golby; Peter M Black; Simon K Warfield
Journal:  Neuroimage       Date:  2006-12-23       Impact factor: 6.556

2.  Diffusion tensor imaging of the corticospinal tract before and after mass resection as correlated with clinical motor findings: preliminary data.

Authors:  Bryan J Laundre; Brian J Jellison; Behnam Badie; Andrew L Alexander; Aaron S Field
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 3.  Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review.

Authors:  Peter G Campbell; Pascal Jabbour; Sanjay Yadla; Issam A Awad
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

Review 4.  Special surgical considerations for functional brain mapping.

Authors:  Hussein Kekhia; Laura Rigolo; Isaiah Norton; Alexandra J Golby
Journal:  Neurosurg Clin N Am       Date:  2011-04       Impact factor: 2.509

5.  Diffusion-weighted imaging-guided resection of intracerebral lesions involving the optic radiation.

Authors:  V A Coenen; K K Huber; T Krings; J Weidemann; J M Gilsbach; V Rohde
Journal:  Neurosurg Rev       Date:  2005-03-04       Impact factor: 3.042

6.  Navigated transcranial magnetic stimulation in preoperative planning for the treatment of motor area cavernous angiomas.

Authors:  Wellingson Silva Paiva; Erich Talamoni Fonoff; Marco Antonio Marcolin; Edson Bor-Seng-Shu; Eberval Gadelha Figueiredo; Manoel Jacobsen Teixeira
Journal:  Neuropsychiatr Dis Treat       Date:  2013-12-09       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.